ロード中...
Biomarkers for Allogeneic HCT Outcomes
Allogeneic hematopoietic cell transplantation (HCT) remains the only curative therapy for many hematological malignant and non-malignant disorders. However, key obstacles to the success of HCT include graft-versus-host disease (GVHD) and disease relapse due to absence of graft-versus-tumor (GVT) eff...
保存先:
| 出版年: | Front Immunol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7186420/ https://ncbi.nlm.nih.gov/pubmed/32373125 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.00673 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|